Primera Therapeutics
PrivateLast Round
Accelerator
Dec 29, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Primera Therapeutics is a biotechnology company that develops gene editing therapies to treat mitochondrial diseases by targeting inherited mutant mitochondrial DNA.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Primera Therapeutics Comparables
Compare Primera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latus Bio | 78% | |
| Capsida Biotherapeutics | 78% | |
| Prime Medicine | 74% | |
Primera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Dec 29, 2022 |
Primera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hibiscus BioVentures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 682% MoM, from 49 to 383.
- May 2, 2025
Monthly visitors increased 513% MoM.
Primera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Primera Therapeutics's valuation, stock price, and market status.